💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
polarized macrophages in choroidal neovascularization
1. Polarized macrophages in the pathogenesis
of choroidal neovascularization
Yasuo Yanagi
Associate Professor, Duke NUS medical School
Singapore National Eye Centre, Singapore Eye Research Institute
2. 2
Choroidal neovascularization
and inflammation
CNV maturation, fibrosis
CNV: Immature vessel +
early AMD
complement in drusen
Chronic subclinical
inflammation Inflammation
Vessel maturation,
inflammation↓
= remission
“wound repair response”*
*: Grossniklaus HE Am J Ophthalmol 1992
Inflammatory cells, RPE cells
Glial cells, endothelial cells
Recurrent
inflammation
RPE/choriod interface
prone to inflammation
Background
Treatment
3. 3
Lymphocyte
・ has no effect 1)
・ IL-17,IFN-g-producing Tcells : pro-angiogenic 2)
Granulocyte (neutrophil)
・ promotes CNV formation 3)
Monocyte/macrophage
・ Pro-angiogenic 4,5)
・ Anti-angiogenic 6,7) 1. Tsutsumi-Miyahara C, et al. Br J Ophthalmol 2004
2. Cruz-Guilloty F, et al. Plos One 2014
3. Zhou J, et al. Mol Vis 2005
4. Sakurai E, et al. Invest Ophthalmol Vis Sci 2003
5. Espinosa-Heidmann DG, et al. Invest Ophthalmol Vis Sci 2003
6. Ambati J, et al. Nat Med 2003
7. Apte RS, et al. PLoS Med 2006
Inflammatory cell types involved in CNV
Background
4. 4
WBC
Lymphocyte
Granulocyte
Monocyte macrophage
T cell
B cell
CD4+
CD8+
B220+
eoshinophil
basophil
neutrophil
CD11b+Ly6G+
Ly6Chi (classical =M1)
Ly6Cint (intermediate)
Ly6Clo (alternative =M2)
CD11b+F4/80+
Cell surface markers for immune cells (in mice)
Background
5. 5
C57BL/6 mouse
Inflammatory cells in mouse CNV model
T cells: CD3+CD4+/CD3+CD8+
B cells: B220+
Granulocytes:CD11b+F4/80-Ly6G+
Macrophages/monocytes:
Ly6Chi, Ly6Clo and Ly6Cint/loCD64+
Retina/RPE/choroid
Ly6chi = Classically activated mφ
Ly6clow = Alternatively activated mφ
6. 6
Tan X et al., PLoS ONE 2016
*
*
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Control 1 3 7
Proportionsofinflammatorycellsubtypes(%)
*
Inflammatory cells in mouse CNV model
CD4+ T cells
B cells
CD8+ T cells
7. 7
Tan X et al., PLoS ONE 2016
*
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Control 1 3 7
Proportionsofinflammatorycellsubtypes(%)
Inflammatory cells in mouse CNV model
Granulocytes
8. 8
Tan X et al., PLoS ONE 2016
*
*
0
0.2
0.4
Control 1 3 7
Proportionsofinflammatorycellsubtypes(%)
*
*
Inflammatory cells in mouse CNV model
Ly6c low macrophages
Ly6c hi macrophages
Ly6c int/low/CD64 macrophages
= alternatively activated Mφ
= classically activated Mφ
9. 9
Laser-induced CNV in Rag2, CD4 and CCR2 KO mice
Contribution of macrophages, but not
B cells and T cells, is crucial for CNV.
0
20000
40000
60000
control Rag2
0
15000
30000
control CD4KO
RAG (recombination-activating gene) 2 KO
Control
Rag2KO
0
20000
40000
60000
control CCR2KO
Control
CD4KO
CD4 KO
CNVarea(μm2)CNVarea(μm2)
CCR2KO
CNVarea(μm2)
10. 10
HE control
CD3: T cells CD68: macrophages
Courtesy of Dr. Hiroyuki Nakashizuka
Immunostaining of CNV samples
Inflammation has been found to play an important role in the development of choroidal neovascularization (CNV).
Firstly, in early age-related macular degeneration (AMD), complement component components can be observed in drusen. and the complement pathways can upregulate the expression of cytokines and their receptors and the recruitment of inflammatory leukocytes, both of which play an important role in the formation of choroidal neovascularization (CNV).
Secondly, histological studies of CNV revealed the involvement of macrophages and other immune cells besides RPE, glial cells and endothelial cells.
Such inflammation is considered to subside with treatment, but persistent inflammation at the RPE/choroid interface is considered to trigger recurrence.
However, regarding the roles of each type of immune cells, previous investigations are not consistent. A few studies have also suggested that T cells contribute to CNV formation. There is a report showing that granulocyte may promote CNV formation. Regarding monocyte and macrophages, the results are controversial; a depletion of macrophage was found to correlate with reduced CNV formation. Conversely, there are reports that intraocular injection of macrophages actually reduces CNV size
The discordant results of the previous results may be due to the difference in the markers used in those studies. In our studies, we first used flow cytometry to evaluate temporal changes in the proportions of lymphocytes, granulocytes, and macrophages in the posterior segment of the eye. This list the markers used in the current study.
Importantly, macrophages are known to polarize into specific subtypes and play divergent roles depending on the context. However, we notice that in most of previous studies, the phenotype of the cells were not sufficiently characterized, thus calling them M1 or M2 (or classically and alternatively actoavted) is not precise. We used Ly6G/Ly6C system in combination with other markers to characterize macrophages.
We induced CNV lesions by laser photocoagulation, and we first investigated changes in the proportions of intraocular inflammatory cells during CNV formation following laser injury by flow cytometry.
These are the markers we used for T cells, B cells, Granulocytes and monocytes.
By using Ly6C and CD64 for intraocular macrophages, we could identify three relatively clear ocular subpopulations (Ly6Chi, Ly6Clo and Ly6Cint/loCD64+). Basically, Ly6Chi macrophages are considered as classically activated macrophages, and Ly6clow macrophages are alternatively activated macrophages
T cells CD3+CD4+/CD3+CD8+
B cells B220+
Granulocytes:CD11b+F4/80-Ly6G+
Macrophages/monocytes:CD11b+Ly6G-F4/80+Ly6Chi/int/lo
As shown here, the proportion of CD4+ T cells recruited into the posterior segment of the eye relative to the total, increased progressively from day 3 to day 7 after laser injury. In contrast, there were no changes in the proportion of CD8+ T cells after injury.
The proportions of granulocytes also increased significantly at day 3 after laser injury and dropped thereafter.
The proportions of two intraocular macrophage subtypes (that is, classically and alternatively activated macrophages) increased significantly at day 3 after laser injury and dropped thereafter. Ly6Cint/loCD64+ subtype showed a higher percentage at day 7 after laser injury.
Then, using a laser-induced CNV model we examined lesion size in mice lacking inflammatory cells or macrophage-depleted mice.
Firstly, to determine the involvement of lymphocytes in CNV, we compared CNV areas in Rag2–/– and CD4–/–mice to their respective WTs.
Rag2 deficient mice lack T and B lymphocytes due to an inability to initiate rearrangement of the T cell receptor and Ig loci,
CD4-deficient mice lack mature T lymphocyttes.
There was no significant difference in lesion size between WT and Rag2–/– mice or CD4–/– mice 7 days after laser injury
Next, to examine the effect of monocytes/macrophages, we compared lesion size between CCR2−/− mice and WT mice and found that lesion area was significantly reduced in CCR2−/− mice (62.3% ± 6.1%) compared with WT mice 7 days after laser injury (Fig. 3A and 3C).
Moreover, when macrophages were depleted by clodronate liposomes, lesion area was also significantly reduced (by 45.9 % ± 5.8%) compared with controls.
Taken together, contribution of macrophages, but not B cells and T cells, is crucial for CNV.
Furthermore, in surgically excised membranes from AMD patients, we did not detect any T cells, whereas CD68 macrophages were abundant as previously reported.
As shown here, both classically and alternatively activated macrophages are present in human CNV lesion. However, the role of polarized macrophages has previously not been thoroughly investigated.
So as a first step to investigate the roles of classically and alternatively activated macrophages, we examined the expression of Vegfa164 and Vegfr1 in intraocular classically activated M1 macrophages and alternatively activated M2 macrophages with or without laser treatment by means of RT-PCR.
Vegfa164 expression was barely detected in intraocular M1 or M2 macrophages without laser treatment.
In contrast, Vegfa164 and VEGFR1expression levels were upregulated in intraocular M1 cells after laser injury. In contrast, neither Vegfr1 nor VEGFR1 was not detected in intraocular M2 cells with or without laser treatment
Considering that circulating inflammatory cells migrate into the lesion, we next asked whether there were any changes in the inflammatory cells circulating in peripheral blood. Whereas there was no significant difference in the proportions of alternatively activated macrophages/monocytes in the blood, classically activated macrophages/monocytes circulating in peripheral blood increased until day 7 after laser treatment.
Lets get the story back to CCR2 knockout mice. To clarify the mechanism of reduced CNV size in CCR2 knockout mice, we assessed the changes in intraocular macrophage and peripheral blood monocyte subtype frequencies after laser injury.
As expected, classically activated macrophages both in the eye and peripheral blood were significantly reduced in CCR2-/- mice compared with controls without laser treatment, at 3 days and 7 days after laser injury.
Interestingly, there were no differences in intraocular alternatively activated monocytes between two groups with or without laser injury, again supporting the role of classically activated monocytes in the activity of CNV.
Bone marrow and spleen was demonstrated to function as a reservoir for monocytes. We thought these findings indicate that monocytes/macrophages derived from bone marrow and/or the spleen, may contribute to CNV formation. So using mice treated with β3 receptor antagonist and splenic-denervated mice, we sought to confirm the involvement of bone marrow- and spleen-derived monocytes/macrophages, in exacerbating CNV lesion size. The results demonstrated that lesion size was significantly reduced in both groups of mice (65.3% ± 1.0%, 39.5% ± 5.6%, and 52.6% ± 11.9%, respectively) compared with controls 7 days after laser injury.
Finally, to investigate the involvement of Ly6Chi macrophage/monocyte infiltration into the posterior segment of eye in CNV formation, we injected classically activated monocytes harvested from spleen into splenic-denervated mice before laser photocoagulation. The reduction in lesion size in splenic-denervated mice compared with controls was significantly increased in the adoptive transfer model of laser-induced CNV.
Lastly, we injected Ly6Chi cells harvested from the spleens of Ly5.1 mice into Ly5.2 mice, and compared the proportion of donor-derived intraocular Ly6Chi macrophages among control, splenic-denervated mice and splenectomized mice. Compared with controls, though donor-derived Ly6Chi cells were infiltrated into the eyes of recipient mice, the proportion of intraocular spleen-derived Ly6Chi cells was reduced in splenic-denervated and splenectomized mice after laser injury. However, there was no difference in the proportion of Ly6chi monocytes in the peripheral blood in splenic denervated mice.
So to conclude my talk, importantly, our results demonstrated that classically activated macrophages/monocytes exacerbates CNV in mice, first.
Second, activated monocytes are derived from bone marrow and spleen-derived Ly6Chi cells might play a role in the development of CNV even though they were not directly recruited into the peripheral blood.
Lastly, sympathetic activity might contribute to CNV via the recruitment of macrophages to the eye.
Although splenectomy is not a realistic treatment, we believe that treatment with systemic b blockers to decrease local inflammation might be feasible.
This work was conducted by our Ph.D student, Dr. Tan. I would like to express my utmost gratitude to Dr. Tan for her contribution to this work.